BOERNER CHRISTOPHER S.
SEC CIK 1543747 · EDGAR
BoughtSold
Most active insiders at CL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wallace Noel R. | COB, Pres, CEO, Dir | — | $33.98M |
| 2 | SUTULA STANLEY J III | CFO | — | $9.22M |
| 3 | Tsourapas Panagiotis | COO, Eur, APac, Afr Eur, Skin | — | $5.70M |
| 4 | Massey Sally | CHRO | — | $2.36M |
| 5 | Daniels Jennifer | CLO, Sec | — | $2.08M |
| 6 | Hazlin John | Chief Growth Off | — | $1.98M |
| 7 | Malcolm Gregory | EVP, Ctrl | — | $1.41M |
| 8 | CAHILL JOHN T | Dir | — | $389.4K |
| 9 | Fishbone Betsy | CLO, Sec | — | — |
| 10 | GRANT SHANE | COO, Americas | — | — |
| 13 | BOERNER CHRISTOPHER S. | Dir | — | — |
Transactions 37
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-13 16:46 | 2026-05-11 | CL | Colgate-Palmolive | BOERNER CHRISTOPHER S. | Dir | A - Grant | $0.00 | +1,383 | 1,383 | New | $0 |
| DM | 2026-03-12 | 2026-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | J - Other | $0.00 | -30.0K | 26.1K | -54% | $0 |
| DM | 2026-03-12 | 2026-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | F - Tax | $60.13 | -21.2K | 21.5K | -50% | -$1.28M |
| DM | 2026-03-12 | 2026-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | M - OptEx | $0.00 | +71.5K | 10.8K | New | $0 |
| D | 2025-11-04 | 2025-11-01 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | J - Other | $0.00 | -544 | 2,420 | -18% | $0 |
| D | 2025-11-04 | 2025-11-01 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | M - OptEx | $0.00 | +2,964 | 2,964 | New | $0 |
| D | 2025-11-04 | 2025-11-01 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | F - Tax | $46.07 | -1,238 | 1,182 | -51% | -$57.0K |
| 2025-06-16 | 2025-06-13 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | G - Gift | $0.00 | -62.7K | 0 | -100% | $0 | |
| I | 2025-06-16 | 2025-06-13 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | G - Gift | $0.00 | +62.7K | 125.4K | +100% | $0 |
| I | 2025-06-04 | 2025-06-03 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | G - Gift | $0.00 | +62.7K | 62.7K | New | $0 |
| 2025-06-04 | 2025-06-03 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | G - Gift | $0.00 | -62.7K | 62.7K | -50% | $0 | |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | M - OptEx | $0.00 | +60.0K | 152.9K | +65% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | J - Other | $0.00 | -17.4K | 138.3K | -11% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | F - Tax | $63.11 | -21.8K | 110.5K | -16% | -$1.38M |
| 2025-02-21 | 2025-02-20 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | P - Purchase | $55.05 | +2,000 | 104.6K | +2% | +$110.1K | |
| D | 2024-11-05 | 2024-11-01 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | F - Tax | $54.32 | -1,488 | 102.6K | -1% | -$80.8K |
| D | 2024-11-05 | 2024-11-01 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | M - OptEx | $0.00 | +2,964 | 104.2K | +3% | $0 |
| D | 2024-11-05 | 2024-11-01 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | J - Other | $0.00 | -55 | 104.1K | -0.1% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | F - Tax | $53.79 | -19.4K | 87.9K | -18% | -$1.04M |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | M - OptEx | $0.00 | +54.6K | 88.4K | +162% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO, Dir | J - Other | $0.00 | -16.7K | 87.5K | -16% | $0 |
| 2023-12-07 | 2023-12-05 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO | P - Purchase | $49.78 | +2,000 | 82.7K | +2% | +$99.6K | |
| D | 2023-12-05 | 2023-12-02 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO | F - Tax | $50.10 | -1,350 | 80.7K | -2% | -$67.6K |
| D | 2023-12-05 | 2023-12-02 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO | M - OptEx | $0.00 | +2,638 | 82.0K | +3% | $0 |
| 2023-11-30 | 2023-11-28 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | CEO | P - Purchase | $48.86 | +3,071 | 79.4K | +4% | +$150.0K | |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | J - Other | $0.00 | +8,568 | 96.1K | +10% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | M - OptEx | $0.00 | +59.1K | 60.7K | +3,697% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | F - Tax | $65.71 | -34.6K | 54.1K | -39% | -$2.27M |
| D | 2022-12-06 | 2022-12-02 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | F - Tax | $81.13 | -1,349 | 43.3K | -3% | -$109.4K |
| D | 2022-12-06 | 2022-12-02 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | M - OptEx | $0.00 | +2,637 | 44.6K | +6% | $0 |
| 2022-03-16 | 2022-03-14 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | S - Sale | $69.20 | -29.5K | 42.0K | -41% | -$2.04M | |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | A - Grant | $0.00 | +13.4K | 94.3K | +17% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | M - OptEx | $0.00 | +51.7K | 48.5K | New | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | F - Tax | $68.42 | -34.5K | 49.7K | -41% | -$2.36M |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | J - Other | $0.00 | +2,399 | 49.3K | +5% | $0 |
| D | 2021-12-06 | 2021-12-02 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | M - OptEx | $0.00 | +2,638 | 39.9K | +7% | $0 |
| D | 2021-12-06 | 2021-12-02 | BMY | Bristol Myers Squibb | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | F - Tax | $55.41 | -1,350 | 38.5K | -3% | -$74.8K |
Purchase Sale Sale after option exercise All abbreviations